Allison Zheng, MD
RESIDENT
Surgery
School of Medicine

Publications (6)

Top publication keywords:
Pituitary NeoplasmsCysteineProlactinomaTumor MicroenvironmentActivation, MetabolicReceptors, G-Protein-CoupledMolecular BiologyGlioblastomaGene Knockout TechniquesPituitary GlandCystathionineAdenomaBrain NeoplasmsHydrogen PeroxideAntigens, CD

• Multiomic screening of invasive GBM cells reveals targetable transsulfuration pathway alterations.
  The Journal of clinical investigation 2023 Garcia JH, Akins EA, Jain S, Wolf KJ, Zhang J, Choudhary N, Lad M, Shukla P, Rios J, Seo K, Gill SA, Carson WH, Carette LR, Zheng AC, Raleigh DR, Kumar S, Aghi MK
• Socioeconomic differences between medically and surgically treated prolactinomas: a retrospective review of 598 patients.
  Journal of neurosurgery 2023 Osorio RC, Haddad AF, Hart DM, Goldrich N, Badani A, Kabir AS, Juncker R, Oh JY, Carrete L, Peeran Z, Chalif EJ, Zheng AC, Braunstein S, Theodosopoulos PV, El-Sayed IH, Gurrola J, Kunwar S, Blevins LS…
• Multi-omic screening of invasive GBM cells in engineered biomaterials and patient biopsies reveals targetable transsulfuration pathway alterations.
  bioRxiv : the preprint server for biology 2023 Garcia JH, Akins EA, Jain S, Wolf KJ, Zhang J, Choudhary N, Lad M, Shukla P, Gill S, Carson W, Carette L, Zheng A, Kumar S, Aghi MK
• CDK 4/6 inhibitors for the treatment of meningioma.
  Frontiers in oncology 2022 Young JS, Kidwell RL, Zheng A, Haddad AF, Aghi MK, Raleigh DR, Schulte JD, Butowski NA
• Recent advancements in the molecular biology of pituitary adenomas.
  Expert review of endocrinology & metabolism 2022 Zheng AC, Wang EJ, Aghi MK
• CD97 is associated with mitogenic pathway activation, metabolic reprogramming, and immune microenvironment changes in glioblastoma.
  Scientific reports 2022 Safaee MM, Wang EJ, Jain S, Chen JS, Gill S, Zheng AC, Garcia JH, Beniwal AS, Tran Y, Nguyen AT, Trieu M, Leung K, Wells J, Maclean JM, Wycoff K, Aghi MK